This document describes the development and evaluation of bilayer tablets containing capecitabine and ondansetron. The bilayer tablet uses Dual Release Drug Absorption System (DUREDAS) technology, providing sustained release of capecitabine in one layer and immediate release of ondansetron in another layer. Various excipients were evaluated to optimize the drug release profiles from each layer. Pre-formulation studies and tablet evaluations were conducted to develop a cost-effective bilayer tablet formulation for once-daily treatment of nausea and vomiting.
Bilayer tablet is suitable for sequential release of two drugs in combination and also for controlled release tablet in which one layer is for immediate release as initial dose and the second layer is for controlled release or maintenance dose. Bilayer tablet is an improved beneficial technology to overcome the shortcoming of the monolayer tablet. This technology avoids frequent administration of dosage form. Now a days such technology is used for co-administration of two drugs like anti-diabetic, anti-hypertensive, anti-inflammatory to the patients. Conventional solid oral dosage forms are a traditional approach, but bilayer tablet is a novel approach that requires new machinery for manufacturing. The technique is cost effective, safe and reproducible.
Self Micro Emulsifying Drug Delivery SystemSagar Savale
The document provides information on self-microemulsifying drug delivery systems (SMEDDS), including their definition, components, mechanism of action, formulation, evaluation, and applications. SMEDDS consist of oils, surfactants, and cosolvents/surfactants that form fine oil-in-water microemulsions upon mild agitation followed by dilution in aqueous fluids. The small droplet size of SMEDDS enhances drug absorption by increasing surface area and promoting intestinal lymphatic transport. SMEDDS have shown improved oral absorption for several poorly soluble drugs over conventional formulations.
This document discusses oral dissolving films (ODFs), which are thin films that dissolve quickly in the mouth. ODFs offer benefits like rapid onset of action, avoidance of first-pass metabolism, improved patient compliance, and ease of administration without water. The document reviews the process of ODF production, current products on the market, potential drugs that could be delivered via ODF, and a study developing a pantoprazole ODF using hydroxypropyl methylcellulose polymers. The study found that the lower viscosity HPMC LV polymer was more effective for rapid film disintegration and drug dissolution compared to the higher viscosity HPMC E 15 polymer.
The document discusses the formulation and evaluation of an artemether sustained release floating bilayer tablet. It aims to develop a floating drug delivery system for artemether to increase its gastric residence time and provide sustained release to ensure optimal drug levels in the blood and minimize side effects. The document provides background on floating drug delivery systems and reviews previous literature on developing such systems for other drugs. It then gives information on the drug artemether and outlines the objectives and methodology that will be used in the study.
This document discusses oral drug delivery systems, specifically oral controlled release systems and gastroretentive drug delivery systems. It defines continuous and pulsatile release oral controlled release systems. Matrix systems and reservoir systems are described as the two main types of continuous release systems. Gastroretentive drug delivery systems are designed to prolong gastric residence time to allow for sustained drug release in the stomach. Approaches for prolonging gastric retention time include high density, floating, swelling/expanding, and mucoadhesive systems. Specific technologies like osmotic pumps, hollow microspheres, and alginate beads are also summarized.
This document provides an overview of osmotic drug delivery systems. It discusses the basic components and principles of osmosis that osmotic drug delivery systems utilize. The key components discussed include the drug, osmogen, semipermeable membrane, and factors that affect drug release such as solubility, osmotic pressure, delivery orifice size, and membrane type. A variety of osmotic pump designs are also briefly mentioned.
Bilayer tablet is suitable for sequential release of two drugs in combination and also for controlled release tablet in which one layer is for immediate release as initial dose and the second layer is for controlled release or maintenance dose. Bilayer tablet is an improved beneficial technology to overcome the shortcoming of the monolayer tablet. This technology avoids frequent administration of dosage form. Now a days such technology is used for co-administration of two drugs like anti-diabetic, anti-hypertensive, anti-inflammatory to the patients. Conventional solid oral dosage forms are a traditional approach, but bilayer tablet is a novel approach that requires new machinery for manufacturing. The technique is cost effective, safe and reproducible.
Self Micro Emulsifying Drug Delivery SystemSagar Savale
The document provides information on self-microemulsifying drug delivery systems (SMEDDS), including their definition, components, mechanism of action, formulation, evaluation, and applications. SMEDDS consist of oils, surfactants, and cosolvents/surfactants that form fine oil-in-water microemulsions upon mild agitation followed by dilution in aqueous fluids. The small droplet size of SMEDDS enhances drug absorption by increasing surface area and promoting intestinal lymphatic transport. SMEDDS have shown improved oral absorption for several poorly soluble drugs over conventional formulations.
This document discusses oral dissolving films (ODFs), which are thin films that dissolve quickly in the mouth. ODFs offer benefits like rapid onset of action, avoidance of first-pass metabolism, improved patient compliance, and ease of administration without water. The document reviews the process of ODF production, current products on the market, potential drugs that could be delivered via ODF, and a study developing a pantoprazole ODF using hydroxypropyl methylcellulose polymers. The study found that the lower viscosity HPMC LV polymer was more effective for rapid film disintegration and drug dissolution compared to the higher viscosity HPMC E 15 polymer.
The document discusses the formulation and evaluation of an artemether sustained release floating bilayer tablet. It aims to develop a floating drug delivery system for artemether to increase its gastric residence time and provide sustained release to ensure optimal drug levels in the blood and minimize side effects. The document provides background on floating drug delivery systems and reviews previous literature on developing such systems for other drugs. It then gives information on the drug artemether and outlines the objectives and methodology that will be used in the study.
This document discusses oral drug delivery systems, specifically oral controlled release systems and gastroretentive drug delivery systems. It defines continuous and pulsatile release oral controlled release systems. Matrix systems and reservoir systems are described as the two main types of continuous release systems. Gastroretentive drug delivery systems are designed to prolong gastric residence time to allow for sustained drug release in the stomach. Approaches for prolonging gastric retention time include high density, floating, swelling/expanding, and mucoadhesive systems. Specific technologies like osmotic pumps, hollow microspheres, and alginate beads are also summarized.
This document provides an overview of osmotic drug delivery systems. It discusses the basic components and principles of osmosis that osmotic drug delivery systems utilize. The key components discussed include the drug, osmogen, semipermeable membrane, and factors that affect drug release such as solubility, osmotic pressure, delivery orifice size, and membrane type. A variety of osmotic pump designs are also briefly mentioned.
The document discusses bi-layer tablets, which contain two layers - an immediate release layer and extended release layer. This allows drugs to be delivered in both an initial and sustained dose. The key properties of bi-layer tablets are that they must maintain integrity without separating, have sufficient strength, and reliably release drugs in a predictable manner. Challenges in manufacturing include preventing delamination, cross-contamination between layers, and lower yields than single layer tablets. Various technologies have been developed to produce bi-layer tablets, including those that use push-pull and osmotic mechanisms to control drug release over time. Recent developments continue to improve bi-layer tablets for delivering multiple or incompatible drugs.
FORMULATION AND EVALUATION OF GELATIN MICROSPHERES LOADED WITH FENOFIBRATEReshma Fathima .K
The document summarizes the formulation and evaluation of gelatin microspheres loaded with the drug Fenofibrate. Two microsphere formulations were developed using a coacervation and phase separation method. Formulation F2 showed 97% drug encapsulation efficiency and released the drug over 12 hours, indicating it was suitable for oral sustained release. Evaluation tests on the microspheres showed they were spherical in shape, had good flow properties, and released the drug in a controlled manner without any burst release. The microspheres could facilitate the design of hard gelatin capsules for improved patient compliance.
This document presents a formulation and evaluation of flurbiprofen loaded emulgel. It begins with an introduction to transdermal drug delivery systems and their advantages over other routes of administration. It then discusses skin anatomy and physiology, the mechanisms of percutaneous absorption, and factors affecting topical absorption. The document provides background on rheumatoid arthritis and defines emulgel. It discusses the ideal properties of emulgel and provides advantages and disadvantages. The objectives and plan of work are then outlined which include literature review, preformulation studies, formulation development, evaluation studies, and stability testing. Finally, the document presents a literature review of several other emulgel formulations.
Self Emulsifying Drug Delivery System (SEDDS)Ashutosh Panke
This document discusses Self-Emulsifying Drug Delivery Systems (SEDDS), which are isotropic mixtures of oils, surfactants, and co-solvents that can solubilize drugs and promote self-emulsification. SEDDS enhance oral drug bioavailability, protect drugs from the hostile gastrointestinal environment, and reduce variability. The document describes the components of SEDDS including oils, surfactants, co-surfactants and drugs. It also outlines the formulation process and methods to evaluate parameters like stability, dispersibility, droplet size and drug release. SEDDS are a promising approach for improving oral delivery of poorly soluble drugs.
Microencapsulation methods can be categorized into physical or physico-chemical methods. Physical methods include pan coating, air suspension, spray drying, and centrifugal extrusion which use mechanical means to apply encapsulating materials onto core particles. Physico-chemical methods use phase separation and polymerization reactions, such as coacervation, supercritical fluid extraction, and sol-gel encapsulation, to form encapsulating shells around active ingredients.
Formulation, Development and Evaluation of Uncoated Bi-layer Tablet of Anti-H...Mohanish Shah
This document presents work on developing a bilayer tablet containing metoprolol succinate and hydrochlorothiazide for the treatment of hypertension. The bilayer tablet uses Dual Release Drug Absorption System (DUREDAS) technology to provide sustained release of metoprolol from one layer and immediate release of hydrochlorothiazide from the other layer. Preliminary studies were conducted to select polymers for the sustained release layer and superdisintegrants for the immediate release layer. Calibration curves were developed for both drugs alone and in combination. Materials and equipment used in the experimental work are listed.
This document discusses various study designs used in bioequivalence studies. It describes the objectives of such studies as determining if a test product is bioequivalent to a reference product when administered at the same molar dose under similar conditions. Some key study designs discussed include non-replicated parallel studies for long-acting drugs, multiple dose steady state studies, and clinical endpoint studies comparing therapeutic effects. Special considerations are also noted for highly variable drugs.
This document discusses sustained release formulations (SRDFs), which are designed to release medication over an extended period of time after a single dose. It defines various types of modified release dosage forms and outlines techniques used in SRDF development, including drug and dosage form modification. Drug candidates suited for SRDFs include those with desirable solubility and a high therapeutic index. The document also examines factors that govern SRDF design such as a drug's physicochemical properties and stability.
Solid dispersion as a technique for enhancement ofBaliram Musale
This document discusses solid dispersion as a technique to enhance the solubility of poorly water soluble drugs. It defines solid dispersion as the dispersion of an active ingredient in an inert carrier in the solid state, prepared through melting, solvent evaporation, or other techniques. The document outlines several mechanisms by which solid dispersions can increase drug solubility, such as reducing particle size and forming soluble complexes. It then describes various techniques for producing solid dispersions, including melting, solvent evaporation, kneading, and hot melt extrusion. Advantages are improved drug solubility and bioavailability, while disadvantages include potential instability over time.
Formulation and Evaluation of Enteric Coated Tablet of Rabeprazole Sodium.Ravindra Lohar
This document presents a dissertation thesis submitted for the degree of Master of Pharmacy in Pharmaceutics. The thesis investigates the formulation and evaluation of enteric coated tablets of Rabeprazole sodium, an anti-ulcer drug. Various studies were conducted including identification of the drug, evaluation of powder blends, drug-excipient compatibility, preparation of core tablets using different disintegrants, and coating of the tablets with an enteric polymer. The formulated tablets were then evaluated for parameters like hardness, thickness, friability, drug content, and disintegration time in acid and buffer media. The results of these evaluations are presented and discussed in the document.
Microspheres are spherical particles ranging from 1 nm to 200 μm that can be used to deliver drugs in a sustained or controlled release manner. They are typically made of biodegradable polymers and can be prepared using various methods like single/double emulsion, polymerization, phase separation, or spray drying. Drugs are encapsulated or absorbed onto the microspheres and released over time as the polymer degrades. Microspheres find applications in areas like vaccines, targeted drug delivery, and imaging due to their advantages of sustained release, increased drug stability and reduced toxicity.
The document summarizes a study on developing a self-microemulsifying drug delivery system (SMEDDS) to enhance the solubility and dissolution of the poorly water-soluble drug candesartan cilexetil. SMEDDS were formulated using oils, surfactants, and cosurfactants. Pseudo ternary phase diagrams were used to optimize the formulations. Solid SMEDDS were developed and showed comparable drug dissolution to liquid SMEDDS. The solid SMEDDS formulations demonstrated enhanced drug release compared to commercial tablets, indicating their potential for improving bioavailability of poorly soluble drugs like candesartan cilexetil.
This document provides an overview of orodispersible tablets. It discusses their history, formulation strategies, evaluation parameters and benefits over conventional tablets. Orodispersible tablets are designed to dissolve rapidly in the mouth without water. They were developed to help patients like children, elderly and those with swallowing difficulties. The key ingredients are superdisintegrants which cause the tablet to break apart quickly. Evaluation tests include hardness, friability, wetting time and in vitro dissolution studies. Orodispersible tablets offer ease of administration, accurate dosing and enhanced bioavailability compared to other dosage forms.
SUSTAINED RELEASE (SR) & CONTROL RELEASE.pptxRAHUL PAL
Sustained-release medications are usually labeled with “SR” at the end of their name. These medications prolong the medication's release from a tablet or capsule so that you'll get the medication's benefits over a longer period of time.
CR = controlled release, SR = sustained release, ER = extended release, IR = immediate release. *
This document provides an overview of solid dispersions including their definition, mechanisms of action, applications, advantages, disadvantages, classification, and methods of preparation. Solid dispersions are defined as dispersions of one or more active ingredients in an inert carrier or matrix at the solid state. They are prepared to improve drug solubility, stability, taste masking, and release profiles. Common classification types include eutectic mixtures, glass solutions, amorphous precipitations, and solid solutions. Preparation methods include melting, solvent evaporation, supercritical fluids, hot melt extrusion, and melting solvent. In conclusion, solid dispersions can effectively enhance solubility and bioavailability of poorly soluble drugs through conversion to amorphous forms and higher
Tablets are solid dosage forms usually obtained by single or multiple compression of powders or granules. In certain cases tablets may be obtained by molding or extrusion techniques. They are uncoated or coated. Tablets are normally right circular solid cylinders, the end surfaces of which are flat or convex and the edges of which may be bevelled. They may have lines or break-marks (scoring), symbols or other markings.Tablets contain one or more active ingredients. They may contain excipients such as diluents, binders, disintegrating agents, glidants, lubricants, substances capable of modifying the behaviour of the dosage forms and the active ingredient(s) in the gastrointestinal tract, colouring matter authorized by the appropriate national or regional authority and flavouring substances. When such excipients are used it is necessary to ensure that they do not adversely affect the stability, dissolution rate, bioavailability, safety or efficacy of the active ingredient(s); there must be no incompatibility between any of the components of the dosage form.
Tablets are single-dose preparations intended for oral administration. Some are intended to be swallowed whole, some after being chewed and some after being crushed, some are intended to be dissolved or dispersed in water before being taken and some are intended to be retained in the mouth where the active ingredient(s) is/are liberated.
This document provides an overview of enteric coating polymers that are used to protect acid-labile drugs and ensure optimal drug absorption. It discusses various categories of enteric coating polymers including polymethacrylates (Eudragit), cellulose esters, and polyvinyl derivatives. Key points include: Eudragit polymers are commonly used methacrylic acid copolymers that are insoluble in gastric fluid but dissolve in the intestine. Cellulose esters like cellulose acetate phthalate are also widely employed. These polymers form films that protect the drug core from gastric conditions and dissolve above pH 6, allowing drug release in the intestines. The solubility and properties of different enteric coating polymers allow controlling
This document provides an overview of microencapsulation techniques with a focus on coacervation phase separation. It defines coacervation as the partial desolvation of a homogeneous polymer solution into a polymer-rich phase and poor polymer phase. The key steps of coacervation formation are the formation of three immiscible chemical phases, deposition of the coating, and rigidization of the coating. Various techniques used for coacervation include changes in temperature, addition of incompatible polymers, addition of non-solvents, addition of salts, and polymer-polymer interactions. Modified coacervation techniques discussed include aqueous phase separation, organic phase separation, solvent evaporation, encapsulation by polyelectrolyte multilayer, hydrogel micro
The document discusses co-processed excipients, which are combinations of two or more excipients designed to physically modify their properties without chemical change. It defines co-processed excipients and provides examples such as microcrystalline cellulose and mannitol. The document outlines the need for co-processed excipients, their manufacturing principles and processes like spray drying. It also discusses the advantages of co-processed excipients in improving flow properties and compressibility as well as their applications and evaluation parameters.
Formulation and evaluation of omeprazole floating tabletsmedicinefda
formulation and evaluation of omeprazole floating tablets, literature review and plan of work ,methods results and discussion,conclusion sample ppt http://www.medicinefda.com/
Formulation and evaluation of lovastatin porous tabletsSriramNagarajan17
This document summarizes the formulation and evaluation of lovastatin porous tablets. Lovastatin tablets were formulated using microcrystalline cellulose, camphor, menthol, crospovidone, crosscarmellose sodium, and magnesium stearate. The tablets were evaluated for parameters like thickness, hardness, friability, weight variation, drug content, and disintegration time both before and after drying. Formulation F6 containing 10% menthol showed the fastest disintegration time of less than 1 minute after drying, indicating menthol is the most effective subliming agent for producing porosity in the tablets. All evaluation parameters were within specified limits. Thus, porous lovastatin tablets with rapid drug release were successfully developed using
The document discusses bi-layer tablets, which contain two layers - an immediate release layer and extended release layer. This allows drugs to be delivered in both an initial and sustained dose. The key properties of bi-layer tablets are that they must maintain integrity without separating, have sufficient strength, and reliably release drugs in a predictable manner. Challenges in manufacturing include preventing delamination, cross-contamination between layers, and lower yields than single layer tablets. Various technologies have been developed to produce bi-layer tablets, including those that use push-pull and osmotic mechanisms to control drug release over time. Recent developments continue to improve bi-layer tablets for delivering multiple or incompatible drugs.
FORMULATION AND EVALUATION OF GELATIN MICROSPHERES LOADED WITH FENOFIBRATEReshma Fathima .K
The document summarizes the formulation and evaluation of gelatin microspheres loaded with the drug Fenofibrate. Two microsphere formulations were developed using a coacervation and phase separation method. Formulation F2 showed 97% drug encapsulation efficiency and released the drug over 12 hours, indicating it was suitable for oral sustained release. Evaluation tests on the microspheres showed they were spherical in shape, had good flow properties, and released the drug in a controlled manner without any burst release. The microspheres could facilitate the design of hard gelatin capsules for improved patient compliance.
This document presents a formulation and evaluation of flurbiprofen loaded emulgel. It begins with an introduction to transdermal drug delivery systems and their advantages over other routes of administration. It then discusses skin anatomy and physiology, the mechanisms of percutaneous absorption, and factors affecting topical absorption. The document provides background on rheumatoid arthritis and defines emulgel. It discusses the ideal properties of emulgel and provides advantages and disadvantages. The objectives and plan of work are then outlined which include literature review, preformulation studies, formulation development, evaluation studies, and stability testing. Finally, the document presents a literature review of several other emulgel formulations.
Self Emulsifying Drug Delivery System (SEDDS)Ashutosh Panke
This document discusses Self-Emulsifying Drug Delivery Systems (SEDDS), which are isotropic mixtures of oils, surfactants, and co-solvents that can solubilize drugs and promote self-emulsification. SEDDS enhance oral drug bioavailability, protect drugs from the hostile gastrointestinal environment, and reduce variability. The document describes the components of SEDDS including oils, surfactants, co-surfactants and drugs. It also outlines the formulation process and methods to evaluate parameters like stability, dispersibility, droplet size and drug release. SEDDS are a promising approach for improving oral delivery of poorly soluble drugs.
Microencapsulation methods can be categorized into physical or physico-chemical methods. Physical methods include pan coating, air suspension, spray drying, and centrifugal extrusion which use mechanical means to apply encapsulating materials onto core particles. Physico-chemical methods use phase separation and polymerization reactions, such as coacervation, supercritical fluid extraction, and sol-gel encapsulation, to form encapsulating shells around active ingredients.
Formulation, Development and Evaluation of Uncoated Bi-layer Tablet of Anti-H...Mohanish Shah
This document presents work on developing a bilayer tablet containing metoprolol succinate and hydrochlorothiazide for the treatment of hypertension. The bilayer tablet uses Dual Release Drug Absorption System (DUREDAS) technology to provide sustained release of metoprolol from one layer and immediate release of hydrochlorothiazide from the other layer. Preliminary studies were conducted to select polymers for the sustained release layer and superdisintegrants for the immediate release layer. Calibration curves were developed for both drugs alone and in combination. Materials and equipment used in the experimental work are listed.
This document discusses various study designs used in bioequivalence studies. It describes the objectives of such studies as determining if a test product is bioequivalent to a reference product when administered at the same molar dose under similar conditions. Some key study designs discussed include non-replicated parallel studies for long-acting drugs, multiple dose steady state studies, and clinical endpoint studies comparing therapeutic effects. Special considerations are also noted for highly variable drugs.
This document discusses sustained release formulations (SRDFs), which are designed to release medication over an extended period of time after a single dose. It defines various types of modified release dosage forms and outlines techniques used in SRDF development, including drug and dosage form modification. Drug candidates suited for SRDFs include those with desirable solubility and a high therapeutic index. The document also examines factors that govern SRDF design such as a drug's physicochemical properties and stability.
Solid dispersion as a technique for enhancement ofBaliram Musale
This document discusses solid dispersion as a technique to enhance the solubility of poorly water soluble drugs. It defines solid dispersion as the dispersion of an active ingredient in an inert carrier in the solid state, prepared through melting, solvent evaporation, or other techniques. The document outlines several mechanisms by which solid dispersions can increase drug solubility, such as reducing particle size and forming soluble complexes. It then describes various techniques for producing solid dispersions, including melting, solvent evaporation, kneading, and hot melt extrusion. Advantages are improved drug solubility and bioavailability, while disadvantages include potential instability over time.
Formulation and Evaluation of Enteric Coated Tablet of Rabeprazole Sodium.Ravindra Lohar
This document presents a dissertation thesis submitted for the degree of Master of Pharmacy in Pharmaceutics. The thesis investigates the formulation and evaluation of enteric coated tablets of Rabeprazole sodium, an anti-ulcer drug. Various studies were conducted including identification of the drug, evaluation of powder blends, drug-excipient compatibility, preparation of core tablets using different disintegrants, and coating of the tablets with an enteric polymer. The formulated tablets were then evaluated for parameters like hardness, thickness, friability, drug content, and disintegration time in acid and buffer media. The results of these evaluations are presented and discussed in the document.
Microspheres are spherical particles ranging from 1 nm to 200 μm that can be used to deliver drugs in a sustained or controlled release manner. They are typically made of biodegradable polymers and can be prepared using various methods like single/double emulsion, polymerization, phase separation, or spray drying. Drugs are encapsulated or absorbed onto the microspheres and released over time as the polymer degrades. Microspheres find applications in areas like vaccines, targeted drug delivery, and imaging due to their advantages of sustained release, increased drug stability and reduced toxicity.
The document summarizes a study on developing a self-microemulsifying drug delivery system (SMEDDS) to enhance the solubility and dissolution of the poorly water-soluble drug candesartan cilexetil. SMEDDS were formulated using oils, surfactants, and cosurfactants. Pseudo ternary phase diagrams were used to optimize the formulations. Solid SMEDDS were developed and showed comparable drug dissolution to liquid SMEDDS. The solid SMEDDS formulations demonstrated enhanced drug release compared to commercial tablets, indicating their potential for improving bioavailability of poorly soluble drugs like candesartan cilexetil.
This document provides an overview of orodispersible tablets. It discusses their history, formulation strategies, evaluation parameters and benefits over conventional tablets. Orodispersible tablets are designed to dissolve rapidly in the mouth without water. They were developed to help patients like children, elderly and those with swallowing difficulties. The key ingredients are superdisintegrants which cause the tablet to break apart quickly. Evaluation tests include hardness, friability, wetting time and in vitro dissolution studies. Orodispersible tablets offer ease of administration, accurate dosing and enhanced bioavailability compared to other dosage forms.
SUSTAINED RELEASE (SR) & CONTROL RELEASE.pptxRAHUL PAL
Sustained-release medications are usually labeled with “SR” at the end of their name. These medications prolong the medication's release from a tablet or capsule so that you'll get the medication's benefits over a longer period of time.
CR = controlled release, SR = sustained release, ER = extended release, IR = immediate release. *
This document provides an overview of solid dispersions including their definition, mechanisms of action, applications, advantages, disadvantages, classification, and methods of preparation. Solid dispersions are defined as dispersions of one or more active ingredients in an inert carrier or matrix at the solid state. They are prepared to improve drug solubility, stability, taste masking, and release profiles. Common classification types include eutectic mixtures, glass solutions, amorphous precipitations, and solid solutions. Preparation methods include melting, solvent evaporation, supercritical fluids, hot melt extrusion, and melting solvent. In conclusion, solid dispersions can effectively enhance solubility and bioavailability of poorly soluble drugs through conversion to amorphous forms and higher
Tablets are solid dosage forms usually obtained by single or multiple compression of powders or granules. In certain cases tablets may be obtained by molding or extrusion techniques. They are uncoated or coated. Tablets are normally right circular solid cylinders, the end surfaces of which are flat or convex and the edges of which may be bevelled. They may have lines or break-marks (scoring), symbols or other markings.Tablets contain one or more active ingredients. They may contain excipients such as diluents, binders, disintegrating agents, glidants, lubricants, substances capable of modifying the behaviour of the dosage forms and the active ingredient(s) in the gastrointestinal tract, colouring matter authorized by the appropriate national or regional authority and flavouring substances. When such excipients are used it is necessary to ensure that they do not adversely affect the stability, dissolution rate, bioavailability, safety or efficacy of the active ingredient(s); there must be no incompatibility between any of the components of the dosage form.
Tablets are single-dose preparations intended for oral administration. Some are intended to be swallowed whole, some after being chewed and some after being crushed, some are intended to be dissolved or dispersed in water before being taken and some are intended to be retained in the mouth where the active ingredient(s) is/are liberated.
This document provides an overview of enteric coating polymers that are used to protect acid-labile drugs and ensure optimal drug absorption. It discusses various categories of enteric coating polymers including polymethacrylates (Eudragit), cellulose esters, and polyvinyl derivatives. Key points include: Eudragit polymers are commonly used methacrylic acid copolymers that are insoluble in gastric fluid but dissolve in the intestine. Cellulose esters like cellulose acetate phthalate are also widely employed. These polymers form films that protect the drug core from gastric conditions and dissolve above pH 6, allowing drug release in the intestines. The solubility and properties of different enteric coating polymers allow controlling
This document provides an overview of microencapsulation techniques with a focus on coacervation phase separation. It defines coacervation as the partial desolvation of a homogeneous polymer solution into a polymer-rich phase and poor polymer phase. The key steps of coacervation formation are the formation of three immiscible chemical phases, deposition of the coating, and rigidization of the coating. Various techniques used for coacervation include changes in temperature, addition of incompatible polymers, addition of non-solvents, addition of salts, and polymer-polymer interactions. Modified coacervation techniques discussed include aqueous phase separation, organic phase separation, solvent evaporation, encapsulation by polyelectrolyte multilayer, hydrogel micro
The document discusses co-processed excipients, which are combinations of two or more excipients designed to physically modify their properties without chemical change. It defines co-processed excipients and provides examples such as microcrystalline cellulose and mannitol. The document outlines the need for co-processed excipients, their manufacturing principles and processes like spray drying. It also discusses the advantages of co-processed excipients in improving flow properties and compressibility as well as their applications and evaluation parameters.
Formulation and evaluation of omeprazole floating tabletsmedicinefda
formulation and evaluation of omeprazole floating tablets, literature review and plan of work ,methods results and discussion,conclusion sample ppt http://www.medicinefda.com/
Formulation and evaluation of lovastatin porous tabletsSriramNagarajan17
This document summarizes the formulation and evaluation of lovastatin porous tablets. Lovastatin tablets were formulated using microcrystalline cellulose, camphor, menthol, crospovidone, crosscarmellose sodium, and magnesium stearate. The tablets were evaluated for parameters like thickness, hardness, friability, weight variation, drug content, and disintegration time both before and after drying. Formulation F6 containing 10% menthol showed the fastest disintegration time of less than 1 minute after drying, indicating menthol is the most effective subliming agent for producing porosity in the tablets. All evaluation parameters were within specified limits. Thus, porous lovastatin tablets with rapid drug release were successfully developed using
This document discusses the formulation and evaluation of mucoadhesive bilayer tablets containing an immediate release layer and sustained release layer of candesartan cilexetil. The bilayer tablets were prepared using a 32 full factorial design to evaluate the effect of two polymers, Eudragit RSPO and RLPO, on drug release. 9 batches of bilayer tablets were developed and evaluated for thickness, hardness, friability, drug content and in vitro drug release over 12 hours. The optimized formulation with desired sustained release was found to follow Higuchi kinetics and non-Fickian drug release mechanism.
The document describes the preparation and evaluation of controlled release matrix tablets of metformin hydrochloride. Ten formulations of matrix tablets were prepared using different amounts of polymers HPMC K100 and Carbapol 934 by direct compression method. The tablets were evaluated for pre-compression and post-compression parameters. In vitro drug release studies showed sustained release of the drug from the matrix tablets over an extended period of time based on the type and concentration of polymer used. The kinetic analysis of drug release indicated that the release followed non-fickian or anomalous transport mechanism.
The document summarizes the development of an extended release formulation of bupropion hydrochloride tablets. The objectives were to develop a stable, cost-effective ER formulation and compare it to marketed products. Various ER tablet formulations were prepared using different concentrations of coating polymers and evaluated for drug release. Formulations F9 and F10, which used 8% coating of ethylcellulose 15cps, showed comparable release to the reference product over 16 hours. The developed formulation met the objectives of providing a once-daily ER tablet for bupropion hydrochloride.
This document provides a synopsis for a Master's thesis project titled "Formulation and Evaluation of Fast Dissolving Films of Lisinopril". The project aims to develop fast dissolving films of the hypertension drug Lisinopril to improve patient compliance. Literature on fast dissolving drug delivery systems and films has been reviewed. The planned work involves preparing Lisinopril films using natural and synthetic polymers through various techniques and evaluating the films for properties like drug content, dissolution, and pharmacodynamics. If successful, the fast dissolving Lisinopril films could provide quick action and ease of administration benefits for hypertension patients.
Formulation and evaluation of mucoadhesive tablets of carvedilol using natura...Nausheen Fatima
Present work describes formulation and evaluation mucoadhesive tablets of Carvedilol using natural binders such as Chitosan and Guar Gum to reduce the first pass metabolism and frequency of administration.
This document describes the formulation and evaluation of oral disintegrating tablets of sumatriptan succinate using superdisintegrants. Sumatriptan succinate tablets were prepared using different concentrations of Croscarmellose sodium and treated agar as superdisintegrants. The tablets were evaluated for various physical properties and drug release. Treated agar at 7.5% concentration showed the fastest disintegration time and wetting time compared to other formulations. The results indicate that treated agar provided better superdisintegrant properties than Croscarmellose sodium for formulating oral disintegrating tablets of sumatriptan succinate.
The document summarizes research on developing enteric-coated tablets of the drug Ramipril to improve its bioavailability and reduce side effects. Immediate-release core tablets were prepared with different superdisintegrants and coated with pH-sensitive polymers Eudragit L-100 and Cellulose Acetate Pthalate. Tablets coated with 9% Cellulose Acetate Pthalate at a coating ratio of 60% triethyl citrate and IPA:DCM 60:40 provided the highest drug release profile in dissolution testing. The optimized formulation aims to protect Ramipril from degradation in the stomach and provide rapid drug release in the intestines.
Formulation and Evaluation of Unidirection Bucco- Adhesive Tablet of Sumatrip...Ajay Champaneri
This document summarizes a research study that formulated and evaluated a unidirectional bucco-adhesive tablet of sumatriptan succinate for the treatment of migraines. The tablet was designed to bypass first-pass hepatic metabolism by delivering the drug through the buccal mucosa. Various polymers including PEO WSR 301 and Carbopol 934p were evaluated as excipients. A 32 full factorial design was used to optimize the tablet formulation based on responses like mucoadhesive strength and drug release profile. Characterization of the optimized formulation showed it provided controlled drug release over 6 hours and had suitable mucoadhesive and swelling properties for buccal delivery.
FORMULATION, EVALUATION AND OPTIMISATION OF SUSTAINED RELEASE FLOATING BILAYE...Dhaneshwar P
This document describes the formulation, evaluation, and optimization of sustained release floating bilayer tablets containing artemether. Thirteen bilayer tablet formulations were developed using a 2-factor, 3-level central composite design with concentrations of HPMC K100M and Carbopol 934P as the independent variables. The dependent variables were total floating time and time for 95% drug release. Pre-formulation studies and evaluation of tablet properties such as drug content, in vitro buoyancy, and in vitro drug release were performed. The optimized formulation F13 showed a floating lag time of 45 seconds, floating for 12 hours, and 98.3% drug release at 12 hours. The study concluded that the developed bilayer floating tablets can
A new precise accurate and reliable validated method for the determination of Capecitabine was developed by using
reverse phase high performance liquid chromatography in pharmaceutical dosage forms. Spectrophotometer
determination was carried out at an absorption maximum of 240nm by using methanol. The linearity was over the
concentration range of 20-120 μg/ml with correlation coefficient 0.999. Chromatographic separation was carried
out by using a mobile phase of methanol: Acetonitrile: water (80:20:80 V/V) on Waters 2487 dual absorbance
column in an isocratic mode at a flow rate of 1.1 ml/min with UV detection at 240 nm. The developed methods were
found to be precise and accurate for the estimation of Capecitabine in pharmaceutical dosage forms and could be
used for routine analysis.
Keywords: Capecitabine, RP-HPLC, Spectrophotometry, Waters 2487 dual absorbance detector, Nova pack 300 ×
3.9mm 5μ as column, 240nm
Design of Pulsatile Tablets of Pantoprazole Sodium: Factorial Design ApproachReshma Fathima .K
This document describes a study that developed and optimized a pulsatile drug delivery system containing pantoprazole sodium using a 32 full factorial design approach. Six core tablets were initially prepared and evaluated. Amounts of microcrystalline cellulose (MCC) and sodium starch glycolate (SSG) were selected as independent variables in the factorial design to study their effects on tablet properties. The optimized core formulation (f3) was then coated with Eudragit S to produce pulsatile tablets. In vitro dissolution studies showed the coated tablets remained intact in acid media and released drug after reaching the intestine, indicating successful development of a pulsatile delivery system for pantoprazole sodium.
This document presents a study on the design and in-vitro evaluation of floating tablets of Gabapentin. Gabapentin was chosen as a model drug candidate for a gastroretentive floating drug delivery system due to its narrow absorption window and solubility issues. A 32 full factorial design was used to study the effect of HPMC K100M polymer concentration and citric acid on tablet properties. Tablets were prepared by direct compression and evaluated for drug release kinetics, which followed Higuchi matrix and zero order models. The optimized batch with 99.06% drug release at 12 hours was found to be GFT7. A stability study showed no changes in this batch over one month. The study demonstrated that floating gabap
Formulation and evaluation of Repaglinide biphasic mini tabletsSriramNagarajan18
This document summarizes the formulation and evaluation of biphasic mini tablets containing repaglinide, an anti-diabetic drug. Immediate release mini tablets were produced using superdisintegrants like sodium starch glycolate and cross povidone. Sustained release mini tablets were developed using polymers like HPMC K100M and ethyl cellulose. The mini tablets were characterized for properties like hardness, friability and drug release. The optimized immediate release formulation showed 99.7% drug release within 15 minutes using sodium starch glycolate. The sustained release formulation using HPMC K100M and ethyl cellulose released drug over 10 hours as desired. The mini tablets were filled into capsules to provide biphasic
This document summarizes the presentation of a new RP-HPLC method for the simultaneous determination of metformin and evogliptin in bulk and pharmaceutical dosage forms. The method utilizes a Waters XTerra RP-18 column with a mobile phase of acetonitrile, potassium dihydrogen phosphate, and methanol. Metformin and evogliptin were well separated with retention times of 2.73 and 4.47 minutes, respectively. The method was validated per ICH guidelines and showed good linearity, accuracy, precision, specificity, robustness and sensitivity. Forced degradation studies indicated the method can separate metformin and evogliptin peaks in the presence of degradation products.
Formulation development and evalution of matrix tablet ofGajanan Ingole
The document describes the development of a matrix tablet for oral delivery of an antihypertensive drug (NSL) using pH dependent and independent polymers. It includes sections on introduction, literature review, drug and excipient profiles, aim and objectives, rationale, materials and equipment, experimental work, results, discussion, and references. The key steps involved preformulation studies, formulation of matrix tablets, optimization studies to match the in vitro dissolution profile of a marketed reference product, and stability studies. The optimized formulation was found to release the drug in a controlled manner for 24 hours.
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Healthy Eating Habits:
Understanding Nutrition Labels: Teaches how to read and interpret food labels, focusing on serving sizes, calorie intake, and nutrients to limit or include.
Tips for Healthy Eating: Offers practical advice such as incorporating a variety of foods, practicing moderation, staying hydrated, and eating mindfully.
Benefits of Regular Exercise:
Physical Benefits: Discusses how exercise aids in weight management, muscle and bone health, cardiovascular health, and flexibility.
Mental Benefits: Explains the psychological advantages, including stress reduction, improved mood, and better sleep.
Tips for Staying Active:
Encourages consistency, variety in exercises, setting realistic goals, and finding enjoyable activities to maintain motivation.
Maintaining a Balanced Lifestyle:
Integrating Nutrition and Exercise: Suggests meal planning and incorporating physical activity into daily routines.
Monitoring Progress: Recommends tracking food intake and exercise, regular health check-ups, and provides tips for achieving balance, such as getting sufficient sleep, managing stress, and staying socially active.
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
MBC Support Group for Black Women – Insights in Genetic Testing.pdfbkling
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
At Apollo Hospital, Lucknow, U.P., we provide specialized care for children experiencing dehydration and other symptoms. We also offer NICU & PICU Ambulance Facility Services. Consult our expert today for the best pediatric emergency care.
For More Details:
Map: https://cutt.ly/BwCeflYo
Name: Apollo Hospital
Address: Singar Nagar, LDA Colony, Lucknow, Uttar Pradesh 226012
Phone: 08429021957
Opening Hours: 24X7
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareDr. David Greene Arizona
Explore the groundbreaking work of Dr. David Greene, a pioneer in regenerative medicine, who is revolutionizing the field of cardiology through stem cell therapy in Arizona. This ppt delves into how Dr. Greene's innovative approach is providing non-surgical, effective treatments for heart disease, using the body's own cells to repair heart damage and improve patient outcomes. Learn about the science behind stem cell therapy, its benefits over traditional cardiac surgeries, and the promising future it holds for modern medicine. Join us as we uncover how Dr. Greene's commitment to stem cell research and therapy is setting new standards in healthcare and offering new hope to cardiac patients.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
Feeding plate for a newborn with Cleft Palate.pptxSatvikaPrasad
A feeding plate is a prosthetic device used for newborns with a cleft palate to assist in feeding and improve nutrition intake. From a prosthodontic perspective, this plate acts as a barrier between the oral and nasal cavities, facilitating effective sucking and swallowing by providing a more normal anatomical structure. It helps to prevent milk from entering the nasal passage, thereby reducing the risk of aspiration and enhancing the infant's ability to feed efficiently. The feeding plate also aids in the development of the oral muscles and can contribute to better growth and weight gain. Its custom fabrication and proper fitting by a prosthodontist are crucial for ensuring comfort and functionality, as well as for minimizing potential complications. Early intervention with a feeding plate can significantly improve the quality of life for both the infant and the parents.
1. “DESIGN AND EVALUATION OF
BILAYER TABLETS OF CAPECITABINE
AND ONDANSETRON”
Register number: 261311006
DEPARTMENT OF PHARMACEUTICS Under the guidance of
CHERRAAN’S COLLEGE OF PHARMACY Dr. N. THIRUMOORTHY,
COIMBATORE-641039 M. PHARM, PH.D.,
2. It comprises of two layers, one of which is sustained release of
Capacetabine and another one is immediate release of
Ondansetron.
Hence, it uses Dual Release Drug Absorption System(DUREDAS)
technology.
To provide once a day dosage form for the treatment of nausea
and vomiting .
As Capacetabine having shorter half life, bilayer tablet provide
extended release of Capacetabine .
Hence reduce dose frequency. Also, Ondansetron formulated as
an immediate release part provides initial relief as is the case with
loading dose in an extended release formulation.
Give additive effect of used both the drugs.
Hence reduce dose dependent side -effects. Also, Ondansetron is
able to overcome the some side effects of Capacetabine.
The process involves reduced manufacturing steps and
manufacturing time and finally makes a cost effective formulation
1. AIM OF PRESENT WORK
3. 2. BILAYER TABLET
Bi-layer tablet which is made up of two Distinct
layers. compressed together with the individual
layers lying one on top of Another.
The administration of sustained release preparation
as one layer with the immediate release preparation
as the second layer is possible. The separation of
two incompatible substances with addition of any
barrier layer between them is possible.
DUal RElease Drug Absorption System
(DUREDAS technology) is a bilayer tablet which can
provide immediate or sustained release of two drugs
or different release rates of the same drug in one
dosage form.
4. 3. LITERATURE REVIEW
Researcher Research Title
M.Sowmya, M.Saritha
Has developed and optimized bilayered sustained
release matrix tablets of Valsartan.
Pandey H developed sustained release bilayer tablet of
domperidone using hydrophilic matrix material such
as HPMC, carbapol and poly-ethylene oxide.
Shirwaikar A. formulated sustained release of Diltiazem
hydrochloride tablets by utilizing the bilayer
concept using matrix material rosin and ethyl
cellulose.
Bhavesh Shiyani et
al.
The aim of this study was to prepare bi-layer tablet
of Metoclopramide Hydrochloride (MTH) and
Ibuprofen (IB) for the effective treatment of
migraine.
Jayabalan Nirmal et
al
formulated bilayer tablets consisting of
atorvastatin calcium (AT) as an immediate
release layer and nicotinic acid (NA) as an
extended release layer.
5. 4. PLAN OF WORK
Pre-formulation studies
Calibration curve.
Flow properties.
Drug excipient compatibilities.
Preparation Of Tablets By Direct Compression Method ( IR
tablets).
Preparation Of Tablets By Direct Compression Method (SR
tablets).
Evaluation of the prepared tablets for various physico-
chemical parameters such as.
Appearance.
Hardness.
Weight variation.
Friability.
Thickness.
In vitro drug release.
Kinetic studies.
6. 4.DRUG PROFILE
Name Capacetabine
Brand names Xeloda
Categories
Antineoplastic
Antimetabolites
Indication For the treatment of patients with metastatic breast cancer
resistant to both paclitaxel and an anthracycline-containing
chemotherapy regimen.
Plasma Half life Capacetabine having shorter half life, 45-60 minutes and its
metabolites.
Mechanism of action Folate cofactor, N5-10-methylenetetrahydrofolate, bind to
thymidylate synthase (TS) to form a covalently bound
ternary complex. This binding inhibits the formation of
thymidylate from 2'-deaxyuridylate.
Absorption Readily absorbed through the GI tract (~70%).
Properties:
State
melting point
Solid
110-121 °C
polarizability 35.81
Dosage forms Tablet oral
7. 4.DRUG PROFILE
Name Ondansetron
Description A competitive serotonin type 3 receptor antagonist. It is
effective in the treatment of nausea and vomiting caused by
cytotoxic chemotherapy drugs.
Category Antiemetics
Indication For the prevention of nausea and vomiting associated with
emetogenic cancer chemotherapy, postoperation, and
radiation.
Mechanism
of action
Ondansetron is a selective serotonin 5-HT3 receptor antagonist.
The antiemetic activity of the drug is brought about through
the inhibition of 5-HT3 receptors present both centrally
(medullary chemoreceptor zone) and peripherally (GI tract).
Absorption
Ondansetron is well absorbed after oral administration and
undergoes limited first-pass metabolism.
Protein binding 70%-76% (Plasma protein binding)
Half life 5.7 hours
State solid
8. EXCIPIENTS
POVIDONE Enhancer; tablet Disintegrant;
dissolution binder.
MAGNESIUM STEARATE Tablet and capsule lubricant .
CROSS POVIDONE (CP) Tablet disintegrant. and dissolution
agent.
SODIUM STARCH GLYCOLATE
(SSG)
Tablet and capsule disintegrant.
Microcrystalline cellulose (MCC) Adsorbent; suspending agent; tablet
and capsule diluent; tablet
disintegrant.
Hydroxy Propyl Methyl Cellelose
(HPMC) Minimize interaction problems when
used in acidic, basic,
Polyvinyle pyrrolydine (PVP)
Binder in wet granulation
Ethyl Cellelose (EC)
Coating agent,
Sodium Lauryl Sulphate (SLS)
Excipient in dissolvable dosage forms.
Talc Lubricant
9. 5.PREFORMULATION & FORMULATIONS STUDY
.PREFORMULATION STUDY:
◦ Organoleptic properties
◦ Solubility
◦ Density
◦ Carr’s compressibility index & Hausner’s ratio
◦ Angle of repose(ɵ)
◦ Compatibility studies
◦ F.T.I.R
FORMULATIONS
The bilayer tablet was prepared by direct compression method.
As shown in Table powder mixtures of Capacetabine,
microcrystalline cellulose, polymers and binder were dry
blended for 20 min followed by addition of Magnesium Stearate
and Talc.
The mixtures were then further blended for 10 min., 400mg of
resultant powder blend was manually compressed using KBr
hydraulic press at a pressure of 1 ton, with a 12mm punch and
die to obtain the tablet.
10. a) First layer fill ; b) First layer tamping;
c) Upper punch withdrawal; d) second layer fill;
e) main compression; f) Ejection;
12. 5.PREFORMULATION & FORMULATIONS STUDY
DIRECT COMPRESSION FOR IMMEDIATE LAYER
All the ingredients were passed through sieve and
mixed in a motor and pestle for 30min for uniform
mixing. The addition of ingredients was done in a
geometrical manner. Then the ondansetron layer was
compressed using 8mm round punch.
COMPOSITION OF IMMEDIATE RELEASE LAYER
14. BILAYERED TABLET PUNCH
After the batch was optimized in both immediate release layer ( F8) and
sustained release layer (F7).The optimized batch in both was
compressed by using same ingredients
Flow Properties
Angle of Repose
Bulk density:
Tapped density
Compressibility index and Hausner ratio
TABLE NO 3 : ACCEPTANCE CRITERIA OF FLOW PROPERTIES
Flow properties Angle of repose(θ) Compressibility
Index (%)
Hausner ratio
Excellent 25-30 <10 1.00-1.11
Good 31-35 11-15 1.12-1.18
Fair 36-40 16-20 1.19-1.25
Passable 41-45 21-25 1.26-1.34
Poor 46-55 26-31 1.35-1.45
Very poor 56-65 32-37 1.46-1.59
Very very poor > 66 >38 >1.6
15. EVALUATION’S PARAMETERS
Appearance
Weight variation test
Thickness test
Hardness test
Friability test
Development of analytical methods
In-vitro studies
Swelling index
Drug content(assay of tablet)
Release of kinetics
Stability study
16. 6. RESULT & DISCUSSION
Pre-compression parameters:
Preformulation studies:
Capacetabine(API)
Physical characterization:
physical characterization of Capacetabine was
studied.
Density and flow properties of drug:
the drug having the excellent flow properties.
Evaluation of Formulated blend: Bulk density,
Tapped density, Carr’s compressibility index ,
Hausner’s ratio and Angle of repose are
studied .the values are within the limits. And
the Formulation blend was good flow property
17. 6. RESULT & DISCUSSION
Preparation of standard calibration
curve of Ondansetron: in 0.1N HCl
calibration curve of Ondansetron in 0.1N HCl
Standard Graph of Capacetabine (0.1 N
Hcl):
calibration curve for Capacetabine in 0.1N HCl
at 303nm
Standard Graph of Capacetabine in
6.8pH phosphate buffer :
calibration curve for capacetabine in 6.8pH
phosphate buffer at 304nm
18. COMPATIBILITY STUDIES
(FTIR) was used for infrared analysis of samples to intercept the
interactions of drug with polymers and other ingredients. The powder
sample along with KBr was used for FTIR studies. The samples were
analyzed between the wave numbers 4000 and 400 cm2.
Fig no 1: FTIR spectra of Capecitabine pure drug
19. Fig no 2: FTIR spectra of Ondansetron pure drug
21. EVALUATION OF PRE COMPRESSION PARAMETERS FOR
SUSTAINED RELAESE LAYER OF CAPACETABINE
Formulations
Angle of Repose (θ)
Loose Bulk
Density (g/ml)
Tapped Bulk
Density (g/ml) %
Compressibility
Hausner’s ratio
22. INVITRO DISSOLUTION STUDIES FOR SR TABLETS -
DISSOLUTION STUDY ( SR TABLETS) :
Acidic Stage:
Medium : 0.1N HCL
Type of apparatus : USP - II (paddle type)
RPM : 50
Volume : 900ml
Temperature : 37ºC± 0.5
Time : 2hrs
Buffer Stage:
Medium : 6.8pH phosphate buffer
Type of apparatus : USP - II (paddle type)
RPM : 50
Volume : 900ml
Time : 24hrs
In vitro dissolution for SR tablets were done initially in 0.1N HCL for 2hrs
and next in 6.8 phosphate buffer for 12hrs
24. Fig No 4- dissolution graph for sustained release formulations
0
20
40
60
80
100
120
0 2 4 6 8 10 12 14
Cumulative%drugrelease
Time in Hrs
F1
F2
F3
F4
F5
F6
F7
F8
F9
F10
25. Dissolution Medium for SR tablets
Table no 5: Dissolution profile of bilayered tablet
S.NO Sampling time
Percentage drug released (%)
ONDANSETRAN CAPACETABINE
1 15mins 80.7 4.2
2 30 mins 99.8 6.6
3 1hr -- 20.6
4 2hr -- 37.7
5 3hr -- 45.4
6 4hr -- 53.8
7 5hr -- 69.7
8 6hr -- 77.9
9 8hr -- 89.0
10 12hr -- 97.3Discussion for in-vitro release of Capacetabine layer SR
From the table, it was confirmed that the F1, F2, F3, F4, F5, F6 and F8 of SR layer
does not fulfill the sustained release theory up to 12 hrs. And also from the table,
it was also confirmed that the formulation made with combination of HPMC K100
and HPMC K4M (F7) showed maximum drug release up to 12hrs.
26. KINETIC RELEASE MODELS:
Drug release kinetics and mechanism:
To analyze the mechanism of drug releasefrom
the formulation, the dissolution profile of all
the batches were fitted to zero order, first
order, Higuchiand Peppasmodels to ascertain
the kinetic modelling of drug release.
• Zero Order: Q = K0 t
• First order: Log Qt = Log Qo+ K1t /
2.303
• Peppas model: Mt/M∞ = ktn
Higuichi model: Q = K2 t1/2
27. y = 1.523x + 0.6649
R² = 0.6341
0
0.5
1
1.5
2
2.5
0 0.2 0.4 0.6 0.8 1 1.2
L
O
G
%
C
D
R
LOG TIME
PEPPAS
y = 8.1531x + 15.432
R² = 0.8791
0
20
40
60
80
100
120
0 5 10 15
%
C
D
R
TIME IN HRS
ZERO ORDER
Fig no 5 - kinetic release graph for F7 sustained release formulation
28. Table no 6:
EVALUATION PARAMETERS FOR IMMEDIATE RELEASE
LAYER OF ONDANSETRANPRE COMPRESSION
PARAMETERSFormulation
s
Angle of
Repose (θ)
Loose Bulk
Density
(g/ml)
Tapped Bulk
Density
(g/ml)
%
Compressibil
ity
Hausner’s
ratio
F1 23.90 0.3 0.35 14.29 1.17
F2 24.20 0.38 0.45 15.56 1.18
F3 27.20 0.53 0.62 14.52 1.17
F4 25.50 0.57 0.68 16.18 1.19
F5 23.80 0.43 0.49 12.24 1.14
F6 24.10 0.37 0.45 17.78 1.22
F7 29.40 0.43 0.5 14.00 1.16
F8 22.100 0.44 0.51 13.73 1.16
F9 26.40 0.4 0.47 14.89 1.18From the above pre-compression parameters it was clear
evidence that drug and excipients has good flow properties and
suitable for direct compression.
29. Post-compression parameters:
Post compression evaluation parameters for immediate
release formulation
The results of the uniformity of weight, hardness,
thickness and friability of the tablets are given in
Table.
All the tablets of different batches complied with the
official requirements of uniformity of weight as their
weights varied between 147 to 152mg.
The hardness of the tablets ranged from 3.1 to
3.6kg/cm2 and the friability values were less than
0.5% indicating that the matrix tablets were compact
and hard.
The thickness of the tablets ranged from to 2.1 to
2.5mm. Thus all the physical attributes of the prepared
tablets were found be practically within control.
32. BILAYERED TABLET COMPRESSION
After the batch was optimized in both immediate release layer (F8) and sustained release
layer (F7).The optimized batch in both was compressed by using same ingredients.
DISSOLUTION STUDY (BILAYERED TABLETS) :
Dissolution Medium for IR tablets
Acidic Stage:
Medium : 0.1N HCL
Type of apparatus : USP - II (paddle type)
RPM : 50
Volume : 900ml
Temperature : 37ºC± 0.5
Time : 30min
In vitro dissolution for IR tablets were done in 0.1N HCL for 30 minutes.
Dissolution Medium for SR tablets
Acidic Stage:
Medium : 0.1N HCL
Type of apparatus : USP - II (paddle type)
RPM : 50
Volume : 900ml
Temperature : 37ºC± 0.5
Time : 2hrs
In vitro dissolution for SR tablets were done in 6.8 pH for 12hrs.
33. Table no 9 : Dissolution profile of bilayered tablet
S.NO Sampling time
Percentage drug released (%)
ONDANSETRAN CAPACETABINE
1 15mins 80.7 4.2
2 30 mins 99.8 6.6
5 1hr -- 20.6
6 2hr -- 37.7
7 3hr -- 45.4
8 4hr -- 53.8
9 5hr -- 69.7
10 6hr -- 77.9
11 8hr -- 89.0
12 12hr -- 97.3
34. Stability Studies
Stability of a drug has been defined as the ability of a particular formulation, in
a specific container, to remain within its physical, chemical, therapeutic and
toxicological specifications.
The purpose of stability testing is to provide evidence on how the quality of a
drug substance or drug product varies with time under
the influence of a variety of environmental factors such as
temperature, humidity, light, and enables recommended
storage conditions.
Overall observations from different evaluation studies such as drug-polymer
interactions, evaluation of prepared formulations and drug release studies
were carried out.
Based on the obtained results best formulation was subjected for further
stability study.
The stability study was conducted as per ICH guidelines for the period of six
months at various accelerated temperature and humidity conditions of
25°C/65%RH, 40°C/75%RH.
The accelerated stability study of the best formulations was carried out as per
the ICH guidelines
36. SUMMARY & CONCLUSION
The Bilayered tablets containing Capacetabine SR and
Ondansetron IR were successfully prepared by direct
compression method respectively.
Various formulations were prepared and evaluated with an
aim of presenting Capacetabine as sustained release and
Ondansetron as immediate release for improving the patient’s
compliance.
The physiochemical evaluation results for the granules of all
trials pass the official limits in angle of repose,
compressibility index.
The prepared blend for IR layer tablets and SR layer tablets
were also maintained the physiochemical properties of tablets
such as thickness, hardness, weight variation, friability.
The optimized formulation F8 in IR formulations contains the
average thickness of 2.4mm, average hardness of 3.4 kg/cm2,
average weight of 149mg, friability of 0.43%.
37. SUMMARY & CONCLUSION
The optimized formulation F7 in SR formulations contains the
average thickness of 2.3mm, average hardness of 7.3 kg/cm2,
friability of 0.41%.
The F7 formulation which releases the capacetabine in sustained
manner in 1st hour it releases 25.5% but the remaining drug
release was sustained up to 12 hours and ondansetron immediate
release F7 formulation showed 96 % drug release with in 30 min.
With the data of kinetic analysis, F7 formulation showed best
linearity in Higuchi’s Equation plot indicating that the release of
drug from matrix tablet follows Non Fickian diffusion.
The dissolution study was carried out for optimized bilayer tablet
and it correlates with the drug release of individual release layer
formulations.
“Hence it may be summarized that the tablets prepared by direct
compression method for sustained release layer and immediate
release layer might be a perfect and effective formulation to
prevent the side effects in treating cancer”.
38. BIBLIOGRAPHY
AM raggi; R mandrioli; A ferranti; J. Pharm. Biomed. Analysis., 2003, 32, 1037-1044.
Bhavesh shiyani, surendra gattani, and sanjay surana formulation and evaluation of bi-
layer tablet of metoclopramide hydrochloride and ibuprofen .Aaps pharma
scitech.Sep2008;9(3) 818-827.
Chien yw. Controlled and modulated release drug delivery system in swarbrik J, boylan JC
(eds.). Encyclopaedia of pharmaceutical technology, marcel dekker, new york, 1990: 281-
313.
Chinam n, arethi b,pandith,singh p,maeduri v design and evaluation of sustained release
bilayer tablet of propranolol hydrochloride. Acta pharm.2007 aug 20;57:479-89.
Deelip derle, omkar joshi, ashish pawar, jatin patel, amol jagadale formulation and
evaluation of buccoadhesive bi-layer tablet of propranolol hydrochloride. International
journal of pharmacy and pharmaceutical sciences, vol. 1, issue 1, july-sep. 2009
E rippe. Compression of solids and compressed dosage forms. In: encyclopedia of
Girish S. Sonara, devendra K. Jaina, dhananjay M. More preparation and in vitro evaluation
of bilayer and fl oating-bioadhesive tablets of rosiglitazone maleate. Bilayer and floating-
bioadhesive tablets of rosiglitazone maleate/asian journal of pharmaceutical sciences 2007,
2 (4): 161-169.
Grabowski sr. Principles of anatomy and physiology. 10th ed. New york:john willey and
sons; 2002: 866-873.
Indian pharmacopoeia. Vol. II, 4th ed. Thecontroller of publications, new delhi,1996, p736
J siepmann; H kranz; R bodmeier; NA peppas; pharm res., 1999, 16, 1748-1756.
Kulkarni a, bhatia m development and evaluation of regioselective bilayer floating tablets
of atenolol and lovastatin to give immediate release of lovastatin and sustained release of
atenolol.Iranian journal of pharm,research. 2009 june 8(1):15-25.
39. Silvina ab, maria cl, claudio js. In-vitro studies of diclofenac sodium controlled-
release from biopolymeric hydrophilic matrices. J pharm pharmaceut sci.
2002;5(3):213-219.
Talwar n, sen h, staniforth jn, inventors. Orally administered controlled drug
delivery system providing temporal and spatial control. Jul 2001. Us patent 6261
601.
The united states pharmacopoeia. 29th edn., Asian edition. Rockville, md: usp
conventional inc: 2006, 2673-2680.
Tripathi kd. Essentials of medical pharmacology, 2009, 6th edition, pg 627-651.
Upendra kumar sharma , himanshu pandey and avinash chandra pandey.
Controlled release of an anti- emetic agent from a polymeric matrix: formulation
and in-
Valentina r, alberto r, giorgio r, monica c. Increased absorption rate of diclofenac
from fast acting formulation containing its potassium salt. Arzneimittel-forschung
2001;51(11):885-90.
Vishnu m patel., Bhupendra g. Et al mucoadhesive bilayer tablets of propranolol
hydrochloride. Aaps pharmscitech. Sep 2007; 8(3): e203–e208.
Vishnu m. Patel,1 bhupendra g. Prajapati,1 and madhabhai m. Patel formulation,
evaluation, and comparison of bilayered and multilayered mucoadhesive buccal
devices of propranolol hydrochloride. Aaps pharmscitech 2007; 8 (1) article 22
(http://www.Aapspharmscitech.Org).
Vitro study. Pandey et al., Ijpsr, 2011; vol. 2(10): 2746-2749 .
Yassin el-said hamza and mona hassan aburahma design and in vitro evaluation
of novel sustained-release double-layer tablets of lornoxicam: utility of
cyclodextrin and xanthan gum combination. Aaps pharmscitech. 2009 dec